What is the importance of the three month milestone monitoring visit?

Patient FAQs published on October 9, 2015
Download Transcript Download Audio
What is the importance of the three month milestone monitoring visit?
Once you have been started on a medication for the treatment of your chronic myeloid leukemia, your doctor will want to follow you to make sure that you are responding. He or she may do this by monitoring your blood studies with something called a PCR every 3 months for the first several years. Initially, that PCR value may be very high in the range of 100% indicating that you have a lot of cancer, but gradually with treatment, it will fall. Over time, the doctor will say you are meeting a milestone, and at 3 months for example, we want to see that value below 10% suggesting that you are on the pathway having good response.

MediCom Worldwide, Inc. acknowledges the collaborative support from The Leukemia & Lymphoma Society (LLS).

Additional Resources
www.LLS.org/CML - CML webpage with links to resources
www.LLS.org/booklets - Chronic Myeloid Leukemia (booklet) and Chronic Myeloid Leukemia Guide(easier to read booklet)
www.LLS.org/PCR - Financial Assistance for PCR test
www.LLS.org/educationvideos - Two videos - CML: The Role of PCR Testing and Resistant Myeloid Leukemia
www.myPCR.org - Coalition of CML-focused organizations provides information about PCR, campaign to increase awareness of the need to monitor CML treatment, and resources for patients.

Last modified: April 4, 2016